Fujifilm Medical Systems U.S.A is set to unveil its new long-length digital radiography (DR) detector at the 2016 American Association of Orthopaedic Surgeons (AAOS) Annual Meeting.


The meeting will be held in Orlando, Florida, from 1 to 5 March.

The new FDR D-EVO GL DR detector, which is for single exposure long-length digital imaging, has received 510(k) approval from the US Food and Drug Administration (FDA).

Incorporating a 17 x 49" field of view, the new DR detector enhances exam acquisition for the patient, to virtually remove chances of movement, which can cause the need for retakes and additional pain, compared to conventional DR stitching systems that require several exposures.

According to the company, D-EVO GL’s DR lowers dose as much as 50% compared to CR long length imaging and images display in seconds compared to minutes.

In addition, the new detector features the firm’s patented ISS and noise reduction detector circuitry, which will help in capturing clear and sharp images at ultra-low doses.

Fujifilm Medical Systems U.S.A marketing and product development director Rob Fabrizio said: "Fujifilm is leading the way in simplifying long length imaging with another game changer in DR, a true ‘first’ and a focus on patient safety.

"We are excited to introduce orthopedic surgeons to the long-awaited benefits that single exposure DR dose reduction and image quality will bring to their patients in the diagnosis, planning and monitoring of scoliosis and long leg orthopedic treatments."

The company provides diagnostic imaging products and medical informatics solutions for healthcare facilities in the US.

It produces digital x-ray systems and cardiovascular products, as well as women’s health imaging systems and others.

Image: Fujifilm’s FDR D-EVO GL is the world’s first long-length DR detector. Photo: courtesy of Business Wire.